Holen Sie sich die Stockscreener-App
0.761
1.17%
-0.009
Handel nachbörslich:
.76
-0.001
-0.13%
Immunic Inc Aktie (IMUX) Neueste Nachrichten
CEO Moves: Is Immunic Inc. in a long term uptrendJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - classian.co.kr
Full technical analysis of Immunic Inc. stockTrade Exit Summary & Reliable Intraday Trade Alerts - Newser
Sentiment analysis tools applied to Immunic Inc.Weekly Investment Recap & Weekly Return Optimization Plans - Newser
Using flow based indicators on Immunic Inc.July 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
How volatile is Immunic Inc. stockMarket Sentiment Report & Verified Short-Term Plans - خودرو بانک
What is the PEG ratio of Immunic Inc.Quarterly Portfolio Summary & Growth Focused Entry Point Reports - خودرو بانک
What’s next for Immunic Inc. stock priceWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Key metrics from Immunic Inc.’s quarterly dataJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - Newser
Does Immunic Inc. stock have upside surprise potentialQuarterly Portfolio Review & Expert Curated Trade Ideas - خودرو بانک
Is Immunic Inc. in a long term uptrendJuly 2025 Patterns & Real-Time Buy Signal Alerts - خودرو بانک
Can Immunic Inc. reach resistance levels soonQuarterly Profit Summary & Weekly Watchlist for Consistent Profits - خودرو بانک
Is Immunic Inc. affected by consumer sentiment2025 Earnings Surprises & Low Risk High Win Rate Picks - خودرو بانک
Sector ETF performance correlation with Immunic Inc.Weekly Stock Analysis & AI Based Buy/Sell Signal Reports - Newser
Immunic : Presentation (20250904 Immunic Company+Overview September 2025) - MarketScreener
Is it too late to sell Immunic Inc.Market Trend Review & Consistent Profit Trading Strategies - Newser
What candlestick patterns are forming on Immunic Inc.Trade Ideas & Long Hold Capital Preservation Tips - Newser
Immunic Inc. stock trendline breakdownEarnings Trend Report & Low Risk Entry Point Tips - Newser
Is Immunic Inc. stock a value trapQuarterly Portfolio Review & Free Daily Entry Point Trade Alerts - خودرو بانک
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Quantisnow
Will Immunic Inc. outperform the marketGap Down & Free Long-Term Investment Growth Plans - Newser
Analyzing drawdowns of Immunic Inc. with statistical toolsJuly 2025 Highlights & Daily Stock Trend Watchlist - Newser
Immunic to Participate in Investor and Scientific Conferences in September - The Malaysian Reserve
Smart tools for monitoring Immunic Inc.’s price actionMarket Trend Summary & High Accuracy Investment Signals - Newser
What are the future prospects of Immunic Inc.Weekly Profit Recap & Expert Verified Stock Movement Alerts - خودرو بانک
Is Immunic Inc. a good ESG investment2025 Growth vs Value & Detailed Earnings Play Strategies - خودرو بانک
Immunic Inc. recovery potential after sell offShare Buyback & Real-Time Volume Spike Alerts - Newser
Backtesting results for Immunic Inc. trading strategiesMarket Performance Recap & Technical Confirmation Trade Alerts - Newser
Tools to monitor Immunic Inc. recovery probability2025 Performance Recap & Advanced Swing Trade Entry Plans - Newser
Statistical indicators supporting Immunic Inc.’s strengthQuarterly Earnings Report & Technical Entry and Exit Alerts - Newser
How to escape a deep drawdown in Immunic Inc.Portfolio Risk Summary & Reliable Entry Point Trade Alerts - Newser
Heatmap analysis for Immunic Inc. and competitorsBond Market & Technical Pattern Alert System - Newser
Combining machine learning predictions for Immunic Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
B. Riley Financial, Inc. shares fall 2.20% after-hours following price target adjustments on Immunic and Celsius Holdings. - AInvest
Is Immunic Inc. forming a bottoming baseJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - Newser
Is Immunic Inc. meeting your algorithmic filter criteriaWeekly Trend Recap & Community Trade Idea Sharing Platform - Newser
B.Riley lowers Immunic stock price target to $4 as catalyst-rich period approaches - Investing.com
B. Riley Cuts Price Target on Immunic to $4 From $5, Keeps Buy Rating - MarketScreener
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):